These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

603 related items for PubMed ID: 19454359

  • 21. Carcinosarcoma and sarcomatoid carcinoma of the bladder: clinicopathological study of 41 cases.
    Lopez-Beltran A, Pacelli A, Rothenberg HJ, Wollan PC, Zincke H, Blute ML, Bostwick DG.
    J Urol; 1998 May; 159(5):1497-503. PubMed ID: 9554341
    [Abstract] [Full Text] [Related]

  • 22. Comparison of american joint committee on cancer pathological stage T2a versus T2b urothelial carcinoma: analysis of patient outcomes in organ confined bladder cancer.
    Boudreaux KJ, Clark PE, Lowrance WT, Rumohr JA, Barocas DA, Cookson MS, Smith JA, Chang SS.
    J Urol; 2009 Feb; 181(2):540-5; discussion 546. PubMed ID: 19084855
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
    Kunju LP, You L, Zhang Y, Daignault S, Montie JE, Lee CT.
    J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
    [Abstract] [Full Text] [Related]

  • 25. Decreased DOC-2/DAB2 expression in urothelial carcinoma of the bladder.
    Karam JA, Shariat SF, Huang HY, Pong RC, Ashfaq R, Shapiro E, Lotan Y, Sagalowsky AI, Wu XR, Hsieh JT.
    Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4400-6. PubMed ID: 17671122
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
    Muller S, Su L, Tighiouart M, Saba N, Zhang H, Shin DM, Chen Z.
    Cancer; 2008 Jul 01; 113(1):97-107. PubMed ID: 18473353
    [Abstract] [Full Text] [Related]

  • 28. Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases.
    Jones TD, Kernek KM, Yang XJ, Lopez-Beltran A, MacLennan GT, Eble JN, Lin H, Pan CX, Tretiakova M, Baldridge LA, Cheng L.
    Hum Pathol; 2005 Jul 01; 36(7):718-23. PubMed ID: 16084939
    [Abstract] [Full Text] [Related]

  • 29. Small cell carcinoma of the bladder: a contemporary clinicopathological study of 51 cases.
    Abrahams NA, Moran C, Reyes AO, Siefker-Radtke A, Ayala AG.
    Histopathology; 2005 Jan 01; 46(1):57-63. PubMed ID: 15656887
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Bladder squamous cell carcinomas express psoriasin and externalize it to the urine.
    Celis JE, Rasmussen HH, Vorum H, Madsen P, Honoré B, Wolf H, Orntoft TF.
    J Urol; 1996 Jun 01; 155(6):2105-12. PubMed ID: 8618345
    [Abstract] [Full Text] [Related]

  • 33. Proteomics and immunohistochemistry define some of the steps involved in the squamous differentiation of the bladder transitional epithelium: a novel strategy for identifying metaplastic lesions.
    Celis JE, Celis P, Ostergaard M, Basse B, Lauridsen JB, Ratz G, Rasmussen HH, Orntoft TF, Hein B, Wolf H, Celis A.
    Cancer Res; 1999 Jun 15; 59(12):3003-9. PubMed ID: 10383167
    [Abstract] [Full Text] [Related]

  • 34. [Radical cystectomy in the treatment for bladder carcinoma: results of 125 operated patients].
    Babjuk M, Hanus T, Safarík L, Dvorácek J, Pavlík I, Dusková J.
    Cas Lek Cesk; 2007 Jun 15; 146(10):746-50. PubMed ID: 18020005
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Urothelial carcinoma versus squamous cell carcinoma of bladder: is survival different with stage adjustment?
    Scosyrev E, Yao J, Messing E.
    Urology; 2009 Apr 15; 73(4):822-7. PubMed ID: 19193403
    [Abstract] [Full Text] [Related]

  • 37. Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder.
    Dalbagni G, Parekh DJ, Ben-Porat L, Potenzoni M, Herr HW, Reuter VE.
    BJU Int; 2007 Feb 15; 99(2):281-5. PubMed ID: 17155984
    [Abstract] [Full Text] [Related]

  • 38. [Expression of Ki-67 and p53 in laryngeal squamous cell carcinomas].
    Calli C, Calli A, Pinar E, Oncel S, Demirtaşoğlu F.
    Kulak Burun Bogaz Ihtis Derg; 2005 Feb 15; 15(1-2):9-13. PubMed ID: 16340285
    [Abstract] [Full Text] [Related]

  • 39. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, Okabe M, Yamada H, Kato T, Moriyama H, Kurihara S, Urashima M.
    Oncologist; 2009 Sep 15; 14(9):900-8. PubMed ID: 19726454
    [Abstract] [Full Text] [Related]

  • 40. Separate submission of standard lymphadenectomy in 6 packets versus en bloc lymphadenectomy in bladder cancer.
    Ather MH, Alam Z, Jamshaid A, Siddiqui KM, Sulaiman MN.
    Urol J; 2008 Sep 15; 5(2):94-8. PubMed ID: 18592461
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.